Cite

HARVARD Citation

    Levy, I. et al. (2021). Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1. Clinical microbiology and infection. pp. 1851-1855. [Online]. 
  
Back to record